Home / Current Issue / Paper 1723977
Comparative In Vitro Evaluation of the Antidiabetic Potential of Morinda lucida and Ficus capensis Leaf Extracts
Subject area: Biological & Medical Sciences · Area of research: In Vitro Antidiabetic Activity of Medicinal Plants
Abstract
Oxidative stress and rapid postprandial hyperglycaemia are central features of diabetes mellitus, and plant extracts that scavenge free radicals and inhibit the carbohydrate-digesting enzymes α-amylase and α-glucosidase are of interest as sources of antidiabetic agents. Morinda lucida and Ficus capensis are tropical African medicinal plants with reported antidiabetic uses, but their in vitro activities have not been compared directly under the same conditions. Ethanolic leaf extracts of both plants were evaluated for total phenolic content (TPC; Folin–Ciocalteu), total flavonoid content (TFC; aluminium chloride), DPPH radical-scavenging activity (62.5–1000 µg/mL), ferric reducing antioxidant power (FRAP), and α-amylase and α-glucosidase inhibition, with acarbose as the reference inhibitor. IC50 values were estimated by nonlinear regression. F. capensis had higher TPC (≈240 versus ≈85 µg GAE/mg) and TFC (≈123 versus ≈101 µg QE/mg) than M. lucida. DPPH scavenging at 1000 µg/mL was 77.98 ± 0.33% for F. capensis versus 30.37 ± 0.62% for M. lucida, and FRAP was ≈95 versus ≈20 µg TE/mg. F. capensis showed stronger α-amylase inhibition (IC50 ≈110 versus ≈500 µg/mL; acarbose ≈90 µg/mL) and a slightly lower α-glucosidase IC50 (≈230 versus ≈250 µg/mL; acarbose ≈100 µg/mL). Under the conditions tested, the ethanolic leaf extract of F. capensis showed the stronger antioxidant and carbohydrate-digestive-enzyme inhibitory profile, particularly against α-amylase, whereas M. lucida showed weaker but measurable activity. These in vitro findings support further bioassay-guided and in vivo investigation of both plants as sources of antidiabetic constituents.
Keywords
α-amylase; α-glucosidase; antioxidant activity; Ficus capensis; Morinda lucida
References
[1] Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. https://doi.org/10.1016/j.diabres.2021.109119
[2] Gregg EW, Buckley J, Ali MK, Davies J, Flood D, Mehta R, et al. Improving health outcomes of people with diabetes: Target setting for the WHO Global Diabetes Compact. Lancet. 2023;401(10384):1302–1312. https://doi.org/10.1016/S0140-6736(23)00001-6
[3] Lu Y, Wang W, Liu J, Xie M, Liu Q, Li S. Vascular complications of diabetes: A narrative review. Medicine (Baltimore). 2023;102(40):e35285. https://doi.org/10.1097/MD.0000000000035285
[4] Yaribeygi H, Sathyapalan T, Atkin SL, Sahebkar A. Molecular mechanisms linking oxidative stress and diabetes mellitus. Oxid Med Cell Longev. 2020;2020:8609213. https://doi.org/10.1155/2020/8609213
[5] Anastasiou IA, Tentolouris KN, Lambadiari V, Eleftheriadou I, Tektonidou M, Tentolouris N. Effects of advanced glycation end products via oxidative stress on beta cells: Insights from in vitro and in vivo studies and update on emerging therapies. Mini Rev Med Chem. 2023;23(21):2041–2052. https://doi.org/10.2174/1389557523666230510123038
[6] Caturano A, D'Angelo M, Mormone A, Russo V, Mollica MP, Salvatore T, et al. Oxidative stress in type 2 diabetes: Impacts from pathogenesis to lifestyle modifications. Curr Issues Mol Biol. 2023;45(8):6651–6666. https://doi.org/10.3390/cimb45080420
[7] Omale S, Amagon KI, Johnson TO, Bremner SK, Gould GW. A systematic analysis of anti-diabetic medicinal plants from cells to clinical trials. PeerJ. 2023;11:e14639. https://doi.org/10.7717/peerj.14639
[8] Sivakumar A, Thanu AS, Vishnumukkala T, Ganesh KSVB, Shetty JK, Jagadeesan S, et al. Management of diabetes mellitus using medicinal plants: A review. Bioinformation. 2024;20(7):705–710. https://doi.org/10.6026/973206300200705
[9] Uti DE, Atangwho IJ, Alum EU, Egba SI, Ugwu OPC, Ikechukwu GC. Natural antidiabetic agents: Current evidence and development pathways from medicinal plants to clinical use. Nat Prod Commun. 2025;20(3). https://doi.org/10.1177/1934578X251323393
[10] Sok Yen F, Shu Qin C, Tan Shi Xuan S, Jia Ying P, Yi Le Y, Darmarajan T, et al. Hypoglycemic effects of plant flavonoids: A review. Evid Based Complement Alternat Med. 2021;2021:2057333. https://doi.org/10.1155/2021/2057333
[11] Mahmoud VL, Shayesteh R, Loh TKFY, Chan SW, Sethi G, Burgess K, et al. Comprehensive review of opportunities and challenges of ethnomedicinal plants for managing type 2 diabetes. Heliyon. 2024;10(23):e39699. https://doi.org/10.1016/j.heliyon.2024.e39699
[12] Ansari P, Khan JT, Chowdhury S, Reberio AD, Kumar S, Seidel V, et al. Plant-based diets and phytochemicals in the management of diabetes mellitus and prevention of its complications: A review. Nutrients. 2024;16(21):3709. https://doi.org/10.3390/nu16213709
[13] Ashagrie YN, Chaubey KK, Tadesse MG, Dayal D, Bachheti RK, Rai N, et al. Antidiabetic phytochemicals: An overview of medicinal plants and their bioactive compounds in diabetes mellitus treatment. Z Naturforsch C J Biosci. 2025;80(9–10):457–479. https://doi.org/10.1515/znc-2024-0192
[14] Sknepnek A, Miletić D, Stupar A, Salević-Jelić A, Nedović V, Cvetanović Kljakić A. Natural solutions for diabetes: The therapeutic potential of plants and mushrooms. Front Nutr. 2025;12:1511049. https://doi.org/10.3389/fnut.2025.1511049
[15] Adewole KE, Attah AF, Adebayo JO. Morinda lucida Benth (Rubiaceae): A review of its ethnomedicine, phytochemistry and pharmacology. J Ethnopharmacol. 2021;276:114055. https://doi.org/10.1016/j.jep.2021.114055
[16] Dah-Nouvlessounon D, Chokki M, Noumavo ADP, Cârâc G, Furdui B, Sina H, et al. Ethnopharmacological value and biological activities via antioxidant and anti-protein denaturation activity of Morinda lucida Benth and Momordica charantia L. leaves extracts from Benin. Plants (Basel). 2023;12(6):1228. https://doi.org/10.3390/plants12061228
[17] Del Vecchio G, Zhang L, Sinan KI, Terzic M, Zengin G, Bene K, et al. Different extraction methods shape the phenolic signature and biological activity of Morinda lucida extracts: A novel source of bioactive compounds preparing functional applications. Food Chem. 2024;452:140956. https://doi.org/10.1016/j.foodchem.2024.140956
[18] Abdulkareem AO, Igunnu A, Adefoluke AA, Olatunji LA. Leaf extract of Morinda lucida improves pancreatic beta-cell function in alloxan-induced diabetic rats. Egypt J Basic Appl Sci. 2019;6(1):73–81. https://doi.org/10.1080/2314808X.2019.1666501
[19] Oyetayo FL, Oseni OA, Akinlolu OS, Momodu DU. Antidiabetic, antilipidemic and antioxidant properties of aqueous extracts of Morinda lucida and Nauclea latifolia leaves in alloxan induced rats. Biointerface Res Appl Chem. 2021;11(4):11602–11615. https://doi.org/10.33263/BRIAC114.1160211615
[20] Amadi ANC, Chinedu-Ndukwe PA, Ijioma SN, Uroko RI, Madubike KG. Serum biochemical changes in alloxan-induced diabetic rats and ameliorative effects of Moringa oleifera and Morinda lucida leaf extracts. Maj Obat Tradis. 2022;27(1):15–23. https://doi.org/10.22146/mot.69945
[21] Esievo KB, Anthony SO, Fatokun OT, Kunle OF. Ficus capensis Thunb. (Moraceae): Review of its ethnomedicinal uses, pharmacological activities and phytochemical constituents. Arch Curr Res Int. 2018;12(3):1–7. https://doi.org/10.9734/ACRI/2018/39495
[22] Ezeigwe OC, Nzekwe FN, Nworie CC. In vivo antidiabetic effect of a combination of ethanol extract of Ficus capensis and Cnidoscolus aconitifolius leaves in alloxan-induced diabetic rats. J Med Plants Stud. 2020;8(4):112–118.
[23] Brand-Williams W, Cuvelier ME, Berset C. Use of a free radical method to evaluate antioxidant activity. LWT Food Sci Technol. 1995;28(1):25–30. https://doi.org/10.1016/S0023-6438(95)80008-5
[24] Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: The FRAP assay. Anal Biochem. 1996;239(1):70–76. https://doi.org/10.1006/abio.1996.0292
[25] Kifle ZD, Debeb SG, Belayneh YM. In vitro α-amylase and α-glucosidase inhibitory and antioxidant activities of the crude extract and solvent fractions of Hagenia abyssinica leaves. Biomed Res Int. 2021;2021:6652777. https://doi.org/10.1155/2021/6652777
[26] Aryal D, Joshi S, Thapa NK, Chaudhary P, Basaula S, Joshi U, et al. Dietary phenolic compounds as promising therapeutic agents for diabetes and its complications: A comprehensive review. Food Sci Nutr. 2024;12(5):3025–3045. https://doi.org/10.1002/fsn3.3983
[27] Lam TP, Nguyen Tran NV, Pham LHD, Lai NVT, Dang BTN, Truong NLN, et al. Flavonoids as dual-target inhibitors against α-glucosidase and α-amylase: A systematic review of in vitro studies. Nat Prod Bioprospect. 2024;14:4. https://doi.org/10.1007/s13659-023-00424-w
[28] Cheng J, Li J, Xiong RG, Wu SX, Xu XY, Tang GY, et al. Effects and mechanisms of anti-diabetic dietary natural products: An updated review. Food Funct. 2024;15(4):1758–1778. https://doi.org/10.1039/D3FO04505F
[29] Febriyanti RM, Indradi RB, Maisyarah IT, Iskandar Y, Susanti RD, Lestari D. Alpha-amylase and alpha-glucosidase enzymes inhibition and antioxidant potential of selected medicinal plants used as anti-diabetes by Sundanese community in West Java, Indonesia. BMC Complement Med Ther. 2025;25(1):426. https://doi.org/10.1186/s12906-025-05144-x
How to cite this paper
@article{1723977,
author = {Anawo Timothy, Daikwo Moses Alilu, Tarfa Florence David},
title = {Comparative In Vitro Evaluation of the Antidiabetic Potential of Morinda lucida and Ficus capensis Leaf Extracts},
journal = {Iconic Research And Engineering Journals},
year = {2026},
volume = {10},
number = {4},
pages = {2084-2093},
issn = {2456-8880},
url = {https://www.irejournals.com/formatedpaper/1723977.pdf},
abstract = {Oxidative stress and rapid postprandial hyperglycaemia are central features of diabetes mellitus, and plant extracts that scavenge free radicals and inhibit the carbohydrate-digesting enzymes α-amylase and α-glucosidase are of interest as sources of antidiabetic agents. Morinda lucida and Ficus capensis are tropical African medicinal plants with reported antidiabetic uses, but their in vitro activities have not been compared directly under the same conditions. Ethanolic leaf extracts of both plants were evaluated for total phenolic content (TPC; Folin–Ciocalteu), total flavonoid content (TFC; aluminium chloride), DPPH radical-scavenging activity (62.5–1000 µg/mL), ferric reducing antioxidant power (FRAP), and α-amylase and α-glucosidase inhibition, with acarbose as the reference inhibitor. IC50 values were estimated by nonlinear regression. F. capensis had higher TPC (≈240 versus ≈85 µg GAE/mg) and TFC (≈123 versus ≈101 µg QE/mg) than M. lucida. DPPH scavenging at 1000 µg/mL was 77.98 ± 0.33% for F. capensis versus 30.37 ± 0.62% for M. lucida, and FRAP was ≈95 versus ≈20 µg TE/mg. F. capensis showed stronger α-amylase inhibition (IC50 ≈110 versus ≈500 µg/mL; acarbose ≈90 µg/mL) and a slightly lower α-glucosidase IC50 (≈230 versus ≈250 µg/mL; acarbose ≈100 µg/mL). Under the conditions tested, the ethanolic leaf extract of F. capensis showed the stronger antioxidant and carbohydrate-digestive-enzyme inhibitory profile, particularly against α-amylase, whereas M. lucida showed weaker but measurable activity. These in vitro findings support further bioassay-guided and in vivo investigation of both plants as sources of antidiabetic constituents.},
keywords = {α-amylase; α-glucosidase; antioxidant activity; Ficus capensis; Morinda lucida},
month = {October},
}